Related Experiment Video
Updated: Dec 21, 2025
Author Spotlight: High-Quality Quantum Dot Nanobeads for Sensitive Fluorescent Lateral Flow Immunoassays
Published on: June 28, 2024
Peptide-enabled receptor-binding-quantum dots for enhanced detection and migration inhibition of cancer cells
Ruijuan Zu1,2, Xiaocui Fang1,2, Yuchen Lin1,2
1CAS Key Laboratory of Biological Effects of Nanomaterials and Nanosafety, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
Abstract:
We report the efforts to construct active targeting quantum dots using receptor-binding peptide for enhanced detection and migration inhibition of cancer cells. Peptide E5 has specific binding with chemokine receptor 4 (CXCR4), which is a transmembrane G-coupled receptor involved in the metastasis of various types of cancers. E5 was introduced to the surface of CdSe/ZnS quantum dots via biotin-streptavidin interactions. The constructed CXCR4-targeting quantum dots (E5@QDs) was observed to display improved detection sensitivity and significantly enhanced binding affinity for CXCR4 over-expressed cancer cells, and the ability to inhibit cancer cells migration induced by CXCL12.
Insights
Researchers developed targeted quantum dots (QDs) using a peptide that binds to chemokine receptor 4 (CXCR4). These E5@QDs enhance cancer cell detection and inhibit their migration, offering a new tool for cancer research.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Chemokine receptor 4 (CXCR4) is a key factor in cancer metastasis.
- Targeted therapies are crucial for improving cancer detection and treatment.
Purpose of the Study:
- To construct active targeting quantum dots (QDs) for enhanced cancer cell detection and migration inhibition.
- To utilize peptide E5 for specific binding to CXCR4 on cancer cells.
Main Methods:
- Peptide E5 was conjugated to Cadmium Selenide/Zinc Sulfide (CdSe/ZnS) quantum dots via biotin-streptavidin interactions.
- The resulting E5-conjugated QDs (E5@QDs) were tested for binding affinity and detection sensitivity.
- The ability of E5@QDs to inhibit cancer cell migration was evaluated.
Main Results:
- E5@QDs demonstrated improved detection sensitivity for cancer cells.
- Enhanced binding affinity of E5@QDs to CXCR4-overexpressing cancer cells was observed.
- E5@QDs significantly inhibited cancer cell migration induced by CXCL12.
Conclusions:
- Active targeting quantum dots using peptide E5 show promise for enhanced cancer cell detection.
- These E5@QDs effectively inhibit cancer cell migration, suggesting potential therapeutic applications.
- The study highlights the utility of peptide-functionalized QDs in cancer research and diagnostics.
